Macquarie Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$105M Sell
870,918
-897,114
-51% -$104M 0.62% 31
2025
Q4
$186M Sell
1,768,032
-1,636,827
-48% -$154M 0.81% 16
2025
Q3
$286M Sell
3,404,859
-69,200
-2% -$5.7M 0.33% 41
2025
Q2
$275M Sell
3,474,059
-545,567
-14% -$43.4M 0.34% 36
2025
Q1
$361M Buy
4,019,626
+136,413
+4% +$12.7M 0.45% 22
2024
Q4
$377M Sell
3,883,213
-519,404
-12% -$53.5M 0.46% 23
2024
Q3
$500M Sell
4,402,617
-85,168
-2% -$10.1M 0.54% 17
2024
Q2
$556M Sell
4,487,785
-467,637
-9% -$60.2M 0.64% 13
2024
Q1
$654M Sell
4,955,422
-1,015,610
-17% -$125M 0.74% 11
2023
Q4
$651M Sell
5,971,032
-413,549
-6% -$42.9M 0.75% 12
2023
Q3
$657M Sell
6,384,581
-448,024
-7% -$48.3M 0.83% 11
2023
Q2
$788M Sell
6,832,605
-626,292
-8% -$71.1M 0.9% 9
2023
Q1
$793M Buy
7,458,897
+20,081
+0.3% +$2.17M 0.94% 5
2022
Q4
$826M Sell
7,438,816
-1,326,950
-15% -$136M 0.98% 3
2022
Q3
$755M Sell
8,765,766
-501,216
-5% -$44.7M 0.93% 7
2022
Q2
$845M Sell
9,266,982
-1,357,173
-13% -$120M 0.95% 6
2022
Q1
$871K Sell
10,624,155
-391,287
-4% -$30.8M 0.66% 12
2021
Q4
$844M Sell
11,015,442
-915,657
-8% -$72.9M 0.7% 7
2021
Q3
$896M Buy
11,931,099
+174,848
+1% +$13.3M 0.76% 7
2021
Q2
$914M Buy
11,756,251
+457,121
+4% +$34M 0.75% 9
2021
Q1
$831M Sell
11,299,130
-76,054
-0.7% -$5.61M 1.18% 1
2020
Q4
$888M Sell
11,375,184
-287,678
-2% -$22M 1.3% 1
2020
Q3
$923M Sell
11,662,862
-479,188
-4% -$37.5M 1.56% 1
2020
Q2
$896M Sell
12,142,050
-268,635
-2% -$20.2M 1.54% 1
2020
Q1
$911M Sell
12,410,685
-1,467,766
-11% -$115M 1.87% 1
2019
Q4
$1.2B Buy
13,878,451
+1,418,743
+11% +$117M 1.72% 1
2019
Q3
$1B Sell
12,459,708
-142,131
-1% -$11.4M 1.68% 2
2019
Q2
$1.01B Sell
12,601,839
-329,717
-3% -$25.2M 1.7% 1
2019
Q1
$1.03B Sell
12,931,556
-588,988
-4% -$44.1M 1.75% 1
2018
Q4
$986M Sell
13,520,544
-989,116
-7% -$69.8M 1.9% 1
2018
Q3
$982M Sell
14,509,660
-931,098
-6% -$59.3M 1.6% 2
2018
Q2
$894M Buy
15,440,758
+2,522,364
+20% +$142M 1.54% 2
2018
Q1
$671M Buy
12,918,394
+658,278
+5% +$35.6M 1.22% 22
2017
Q4
$658M Buy
12,260,116
+625,749
+5% +$34.7M 1.16% 29
2017
Q3
$711M Sell
11,634,367
-1,225,186
-10% -$74.3M 1.28% 26
2017
Q2
$786M Sell
12,859,553
-286,291
-2% -$17.4M 1.44% 11
2017
Q1
$797M Sell
13,145,844
-219,980
-2% -$13.3M 1.45% 15
2016
Q4
$751M Buy
13,365,824
+531,286
+4% +$31.1M 1.44% 23
2016
Q3
$764M Sell
12,834,538
-13,842,696
-52% -$809M 1.47% 5
2016
Q2
$1.47B Buy
26,677,234
+13,486,835
+102% +$718M 1.43% 17
2016
Q1
$666M Buy
13,190,399
+857,880
+7% +$42M 1.34% 22
2015
Q4
$622M Buy
12,332,519
+418,622
+4% +$21.1M 1.28% 20
2015
Q3
$561M Buy
11,913,897
+714,244
+6% +$37.9M 1.2% 22
2015
Q2
$608M Buy
11,199,653
+7,638
+0.1% +$428K 1.2% 14
2015
Q1
$614M Buy
11,192,015
+1,068,077
+11% +$60.5M 1.2% 7
2014
Q4
$549M Buy
10,123,938
+991,331
+11% +$55.2M 1.13% 16
2014
Q3
$517M Buy
9,132,607
+649,707
+8% +$36.5M 1.11% 11
2014
Q2
$468M Sell
8,482,900
-193,510
-2% -$10.6M 1.04% 14
2014
Q1
$470M Sell
8,676,410
-156,982
-2% -$8.13M 0.81% 24
2013
Q4
$422M Buy
8,833,392
+758,183
+9% +$34.7M 0.76% 32
2013
Q3
$367M Buy
8,075,209
+489,650
+6% +$22.4M 0.72% 34
2013
Q2
$336M Buy
+7,585,559
New +$339M 0.73% 35

Other funds holding MRK

Macquarie Group's MRK Position: Q1 2026 in Review

Macquarie Group reduced its Merck (MRK) stake by 51% in Q1 2026, selling an estimated $104M and leaving 870,918 shares worth $105M. The position accounts for 0.62% of the portfolio, ranked #31.

Macquarie Group first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.47B in Q2 2016. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Macquarie Group held 870,918 shares of Merck worth $105M as of Q1 2026.
  • Macquarie Group sold 897,114 Merck shares in Q1 2026, an estimated $104M.
  • Merck made up 0.62% of Macquarie Group's portfolio in Q1 2026, its #31 holding.
  • Macquarie Group first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Macquarie Group's Merck position peaked at $1.47B in Q2 2016.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Macquarie Group's 13F filing for Q1 2026, filed 15 May 2026.